GPX3 and Metabolic Disorders Metabolic disorders, including obesity, diabetes, and insulin resistance, pose significant public health challenges due to their high associated morbidity and mortality rates [131]
Each of these affects whether patients seek care at all and what happens when they do
Coverage is increasingly decided at the employer level, with some offering optional riders for an additional premium
Mhasker KS, Caius JF
Tirzepatide did not increase risks of adverse renal events, urinary tract infections, nephrolithiasis (kidney stones), acute kidney injury, or renal cancer compared to placebo, insulin, or other GLP-1 receptor agonists
Long-term outcome for children with autism who received early intensive behavioral treatment